University College London Hospital NHS trust
Welcome,         Profile    Billing    Logout  
 2 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Haidry, Rehan
UK-ENDOMAB, NCT06305208: A UK Registry for Metabolic and Bariatric Endoscopic Interventions

Recruiting
N/A
300
Europe
Endoscopic gastric suturing, Endoscopic sleeve gastroplasty (ESG; Apollo Overstitch), Endoscopic gastric plication, Primary obesity surgery endoluminal (POSE), Endomina system, Revisional gastroplasty, Transoral outlet reduction endoscopy (TORe), Duodenal mucosal resurfacing (DMR), Intragastric balloon(s)
Cleveland Clinic London
Obesity, Diabetes Mellitus, Type 2
02/34
02/39
REVITA-T2Di, NCT04419779: Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes

Suspended
N/A
320
Europe, US
Duodenal Mucosal Resurfacing (DMR), Duodenal Mucosal Resurfacing (Sham)
Fractyl Health Inc.
Type 2 Diabetes
06/25
01/26
TREET, NCT06188585: Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Bleeding Ulcers

Recruiting
N/A
278
Europe, Canada, US, RoW
UI-EWD, Nexpowder™, Conventional therapy, Bipolar electrocoagulation or Bipolar electrocoagulation endoscopic hemostasis, Epinephrine (1:10,000 dilution) injection or Endoscopic hemostatic injection of epinephrine (1:10,000 dilution), Endoscopic hemostatic clip
Medtronic - MITG, North American Science Associates Ltd.
Acute Gastrointestinal Bleeding
07/26
08/26
NCT03364114: Endorotor Resection In Refractory Barrett's Dysplasia Patients

Recruiting
N/A
120
Europe, US
EndoRotor Mucosal Resection System, Continued Ablation
Interscope, Inc.
Barrett's Esophagus With Dysplasia
12/24
12/24
Janes, Samuel
ALPINE, NCT05902559: Assessment of Novel Biomarkers in Participants Undergoing Targeted Lung Health Checks

Recruiting
N/A
10000
Europe
University College, London, Gustave Roussy, Cancer Campus, Grand Paris
Lung Cancer
11/27
11/28
Hough, Rachel
ALLTogether1, NCT04307576 / 2018-001795-38: A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

Recruiting
3
6430
Europe, RoW
Omitted Doxorubicin, Omitted Vincristine+Dexamethasone pulses, Inotuzumab Ozogamicin+Standard Maintenance Therapy, Besponsa+Maintenance Therapy, Imatinib, 6-tioguanine+Standard Maintenance Therapy, Blinatumomab, Blincyto
Mats Heyman, The Swedish Research Council, The Swedish Childhood Cancer Foundation, Pfizer, Servier, NordForsk, Aamu Pediatric Cancer Foundation, German Society for Pediatric Oncology and Hematology GPOH gGmbH, Clinical Trial Center North (CTC North GmbH & Co. KG), Belgium Health Care Knowledge Centre, Karolinska Institutet, Cancer Research UK, Fundação Rui Osório de Castro, Acreditar - Associação de Pais e Amigos das Crianças com Cancro, Grupo Português De Leucemias Pediátricas, Amgen, Nova Laboratories Limited, Danish Child Cancer Foundation, Danish Cancer Society, The Novo Nordic Foundation, Assistance Publique - Hôpitaux de Paris, Direction Générale de l'Offre de Soins
Leukemia, Acute Lymphoblastic
06/27
06/32
RITII, NCT04856215: 90Y-labelled Anti-CD66 ab in Childhood High Risk Leukaemia

Recruiting
2
25
Europe
90-Yttrium-labelled anti-CD66 monoclonal antibody
Great Ormond Street Hospital for Children NHS Foundation Trust
Leukemia
09/25
09/25
Dimakopoulou, Anastasia
NCT05410886: Screening Women for Functional Hypothalamic Amenorrhea (FHA)

Completed
N/A
20
Europe
Questionnaire
Imperial College London, University College, London
Amenorrhea Secondary
02/24
02/24

Download Options